Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2100053118Phase 4Completed
Phase 4, randomised trial comparing Etomidate induction with Remimazolam induction (2 arms). Primary endpoint: Blood pressure. Started Nov 2021; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2100053118.